|
1
|
Swerdlow SH: WHO classification of tumours
of haematopoietic and lymphoid tissues. 2. 4th edition. World
Health Organization; 2008
|
|
2
|
Zhao B: China clinical skin disease
science. Jiangsu Science and Technology Press. 1661:1679–1681.
2009.
|
|
3
|
Li S, Feng X, Li T, et al: Extranodal
NK/T-cell lymphoma, nasal type: a report of 73 cases at MD Anderson
Cancer Center. Am J Surg Pathol. 37:14–23. 2013.
|
|
4
|
Li S, Feng X, Li T, et al: Extranodal
NK/T-cell lymphoma, nasal type: a report of 73 cases at MD Anderson
Cancer Center. Am J Surg Pathol. 37:14–23. 2013.
|
|
5
|
Lister TA, Crowther D, Sutcliffe SB, et
al: Report of a committee convened to discuss the evaluation and
staging of patients with Hodgkin’s disease: Cotswolds meeting. J
Clin Oncol. 7:1630–1636. 1989.
|
|
6
|
Wang Hai ZS and Shi MT: Advances in NK/T
cell lymphoma, nasal type. Chinese Journal of Oncology.
15:1909–1912. 2008.
|
|
7
|
Tlholoe MM, Kotu M, Khammissa RA, Bida M,
Lemmer J and Feller L: Extranodal natural killer/T-cell lymphoma,
nasal type: ‘midline lethal granuloma’. A case report. Head Face
Med. 9:42013.
|
|
8
|
Zhao S, Liu WP, Zhang WY and Li GD:
Extranodal nasal type NK/T-cell lymphoma: the expression of
Epstein-Barr virus latent membrane protein 1 and its significance
of prognosis. Sichuan Da Xue Xue Bao Yi Xue Ban. 36:338–340.
2005.(In Chinese).
|
|
9
|
Kanavaros P, De Bruin PC, Briere J, Meijer
CJ and Gaulard P: Epstein-Barr virus (EBV) in extranodal T-cell
non-Hodgkin’s lymphomas (T-NHL). Identification of nasal T-NHL as a
distinct clinicopathological entity associated with EBV. Leuk
Lymphoma. 18:27–34. 1995.
|
|
10
|
Zhang Y, Peng J, Tang Y, et al: The
prevalence of Epstein-Barr virus infection in different types and
sites of lymphomas. Jpn J Infect Dis. 63:132–135. 2010.
|
|
11
|
Jaffe ES: Nasal and nasal-type T/NK cell
lymphoma: a unique form of lymphoma associated with the
Epstein-Barr virus. Histopathology. 27:581–583. 1995.
|
|
12
|
Jiang Lu ZW and Saijuan Chen: Research on
NK/T cell lymphoma extranodal nasal type. Diagnostic Progress of
Theory and Practice. 11:191–194. 2012.
|
|
13
|
Ohtsuka R, Abe Y, Sada E, et al: Adult
patient with Epstein-Barr virus (EBV)-associated
lymphoproliferative disorder: chronic active EBV infection or de
novo extranodal natural killer (NK)/T-cell lymphoma, nasal type?
Intern Med. 48:471–474. 2009.
|
|
14
|
Kim JE, Kim YA, Jeon YK, Park SS, Heo DS
and Kim CW: Comparative analysis of NK/T-cell lymphoma and
peripheral T-cell lymphoma in Korea: Clinicopathological
correlations and analysis of EBV strain type and 30-bp deletion
variant LMP1. Pathol Int. 53:735–743. 2003.
|
|
15
|
Iqbal J, Kucuk C, Deleeuw RJ, et al:
Genomic analyses reveal global functional alterations that promote
tumor growth and novel tumor suppressor genes in natural
killer-cell malignancies. Leukemia. 23:1139–1151. 2009.
|
|
16
|
Nakashima Y, Tagawa H, Suzuki R, et al:
Genome-wide array-based comparative genomic hybridization of
natural killer cell lymphoma/leukemia: different genomic alteration
patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell
lymphoma, nasal type. Genes Chromosomes Cancer. 44:247–255.
2005.
|
|
17
|
Quintanilla-Martinez L, Franklin JL,
Guerrero I, et al: Histological and immunophenotypic profile of
nasal NK/T cell lymphomas from Peru: high prevalence of p53
overexpression. Hum Pathol. 30:849–855. 1999.
|
|
18
|
Takakuwa T, Dong Z, Nakatsuka S, et al:
Frequent mutations of Fas gene in nasal NK/T cell lymphoma.
Oncogene. 21:4702–4705. 2002.
|
|
19
|
Wang TT, Xu C, Liu SL, et al:
Clinicopathology, immunophenotype, T cell receptor gene
rearrangement, Epstein-Barr virus status and p53 gene mutation of
cutaneous extranodal NK/T-cell lymphoma, nasal-type. Chin Med J
(Engl). 126:1281–1287. 2013.
|
|
20
|
Qi Yingjie LY: Development and prospect of
nasal type NK/T cell lymphoma and clinical treatment of Ren
adorable. Chinese Medicine Guide. 9:205–206. 2011.
|
|
21
|
Yasuda H, Sugimoto K, Imai H, et al:
Expression levels of apoptosis-related proteins and Ki-67 in nasal
NK/T-cell lymphoma. Eur J Haematol. 82:39–45. 2009.
|
|
22
|
Kim SJ, Kim BS, Choi CW, et al: Ki-67
expression is predictive of prognosis in patients with stage I/II
extranodal NK/T-cell lymphoma, nasal type. Ann Oncol. 18:1382–1387.
2007.
|
|
23
|
Huang Y, De Reyniès A, De Leval L, et al:
Gene expression profiling identifies emerging oncogenic pathways
operating in extranodal NK/T-cell lymphoma, nasal type. Blood.
115:1226–1237. 2010.
|
|
24
|
Liu X, Wang B, Ma X and Guo Y: NF-kappaB
activation through the alternative pathway correlates with
chemoresistance and poor survival in extranodal NK/T-cell lymphoma,
nasal type. Jpn J Clin Oncol. 39:418–424. 2009.
|
|
25
|
Piccaluga PP, Gazzola A, Agostinelli C,
Bacci F, Sabattini E and Pileri SA: Pathobiology of Epstein-Barr
virus-driven peripheral T-cell lymphomas. Semin Diagn Pathol.
28:234–244. 2011.
|
|
26
|
Su ZL, Mo XL, Feng ZY, Lin HL and Ding YG:
UBE1 expression in extranodal NK/T cell lymphoma, nasal type. Leuk
Lymphoma. 49:1821–1822. 2008.
|
|
27
|
Yagi H, Seo N, Ohshima A, et al: Chemokine
receptor expression in cutaneous T cell and NK/T-cell lymphomas:
immunohistochemical staining and in vitro chemotactic assay. Am J
Surg Pathol. 30:1111–1119. 2006.
|
|
28
|
Wood PB, Parikh SR and Krause JR:
Extranodal NK/T-cell lymphoma, nasal type. Proc (Bayl Univ Med
Cent). 24:251–254. 2011.
|
|
29
|
Liang DN, Yang ZR, Wang WY, et al:
Extranodal nasal type natural killer/T-cell lymphoma of testis:
report of seven cases with review of literature. Leuk Lymphoma.
53:1117–1123. 2012.
|
|
30
|
Ng SB, Lai KW, Murugaya S, et al:
Nasal-type extranodal natural killer/T-cell lymphomas: a
clinicopathologic and genotypic study of 42 cases in Singapore. Mod
Pathol. 17:1097–1107. 2004.
|
|
31
|
Yang S: Clinical and pathological
characteristics of nasal type NK/T cell lymphoma. Acta Academiae
Medicinae cPAPF. 21:305–309. 2012.(In Chinese).
|
|
32
|
Mraz-Gernhard S, Natkunam Y, Hoppe RT,
LeBoit P, Kohler S and Kim YH: Natural killer/natural killer-like
T-cell lymphoma, CD56+, presenting in the skin: an
increasingly recognized entity with an aggressive course. J Clin
Oncol. 19:2179–2188. 2001.
|
|
33
|
Yanagi H, Nakamura Y, Takagi D and Kubota
K: Extranodal natural killer/T-cell lymphoma: a diagnostic dilemma.
Rhinology. 50:325–331. 2012.
|
|
34
|
Ren X, Jia Q, Xiang G, Zhao Z, Xu K and Du
W: Clinical study of 34 patients with extranodal NK/T cell
lymphoma-nasal type. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za
Zhi. 21:361–362. 2007.(In Chinese).
|
|
35
|
Lou LL, Cen XN, Ou JP, et al: Clinical and
pathological analysis of 236 patients with primary extranodal
lymphoma. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 22:85–92. 2014.(In
Chinese).
|
|
36
|
Shuyun Y: Clinical and pathological
characteristics of nasal type NK/T cell lymphoma. Armed Police
Logistics College (Medical Edition). 21:305–308. 2012.
|
|
37
|
Lee WJ, Jung JM, Won CH, et al: Cutaneous
extranodal natural killer/T-cell lymphoma: a comparative
clinicohistopathologic and survival outcome analysis of 45 cases
according to the primary tumor site. J Am Acad Dermatol.
70:1002–1009. 2014.
|
|
38
|
Li LL, Chai Y, Zhang LS, Dong C and Hao
ZD: A case of blastic plasmacytoid dendritic cell neoplasm and
literatures review. Zhonghua Xue Ye Xue Za Zhi. 34:553–554.
2013.(In Chinese).
|
|
39
|
Cheung MM, Chan JK, Lau WH, Ngan RK and
Foo WW: Early stage nasal NK/T-cell lymphoma: clinical outcome,
prognostic factors, and the effect of treatment modality. Int J
Radiat Oncol Biol Phys. 54:182–190. 2002.
|
|
40
|
Kim TM and Heo DS: Extranodal NK/T-cell
lymphoma, nasal type: new staging system and treatment strategies.
Cancer Sci. 100:2242–2248. 2009.
|
|
41
|
Koom WS, Chung EJ, Yang WI, et al:
Angiocentric T-cell and NK/T-cell lymphomas: radiotherapeutic
viewpoints. Int J Radiat Oncol Biol Phys. 59:1127–1137. 2004.
|
|
42
|
Shikama N, Ikeda H, Nakamura S, et al:
Localized aggressive non-Hodgkin’s lymphoma of the nasal cavity: a
survey by the Japan Lymphoma Radiation Therapy Group. Int J Radiat
Oncol Biol Phys. 51:1228–1233. 2001.
|
|
43
|
Zhao J and Yi C: Advances in the clinical
treatment of nasal and nasal type NK/T cell lymphoma. Chinese
Journal of Clinical Oncology. 33:836–839. 2006.(In Chinese).
|
|
44
|
Kim SJ, Kim K, Kim BS, et al: Phase II
trial of concurrent radiation and weekly cisplatin followed by VIPD
chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal
NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma
study. J Clin Oncol. 27:6027–6032. 2009.
|
|
45
|
Avilés A, Neri N, Fernández R, Calva A,
Huerta-Guzmán J and Nambo MJ: Nasal NK/T-cell lymphoma with
disseminated disease treated with aggressive combined therapy. Med
Oncol. 20:13–17. 2003.
|
|
46
|
You JY, Chi KH, Yang MH, et al: Radiation
therapy versus chemotherapy as initial treatment for localized
nasal natural killer (NK)/T-cell lymphoma: a single institute
survey in Taiwan. Ann Oncol. 15:618–625. 2004.
|
|
47
|
Yang Yong ZY, Ying Sun, et al: Early
extranodal nasal type NK/T cell lymphoma chemotherapy efficacy
analysis. Chinese Journal of Clinical Oncology. 19:378–381.
2012.
|
|
48
|
Sasaki M, Matsue K, Takeuchi M, Mitome M
and Hirose Y: Successful treatment of disseminated nasal NK/T-cell
lymphoma using double autologous peripheral blood stem cell
transplantation. Int J Hematol. 71:75–78. 2000.
|
|
49
|
Reimer P: Impact of autologous and
allogeneic stem cell transplantation in peripheral T-cell
lymphomas. Adv Hematol. 2010:3206242010.
|
|
50
|
Niu T, Chen XC, Xue HL, et al: Aggressive
NK/T lymphoma with autologous hematopoietic stem cell
transplantation. Hua Xi Yi Xue. 12:1763–1766. 2011.(In
Chinese).
|
|
51
|
Shen L, Au WY, Guo T, et al: Proteasome
inhibitor bortezomib-induced apoptosis in natural killer (NK)-cell
leukemia and lymphoma: an in vitro and in vivo preclinical
evaluation. Blood. 110:469–470. 2007.
|
|
52
|
Kim SJ, Yoon DH, Kang HJ, et al:
Bortezomib in combination with CHOP as first-line treatment for
patients with stage III/IV peripheral T-cell lymphomas: a
multicentre, single-arm, phase 2 trial. Eur J Cancer. 48:3223–3231.
2012.
|
|
53
|
Jaccard A, Petit B, Girault S, et al:
L-asparaginase-based treatment of 15 western patients with
extranodal NK/T-cell lymphoma and leukemia and a review of the
literature. Ann Oncol. 20:110–116. 2009.
|
|
54
|
Chim CS, Ma SY, Au WY, et al: Primary
nasal natural killer cell lymphoma: long-term treatment outcome and
relationship with the International Prognostic Index. Blood.
103:216–221. 2004.
|
|
55
|
Liu XL and Zou L: Treatment and research
status of the cutaneous NK/T cell lymphoma. Hua Xi Yi Xue.
27:1745–1748. 2012.(In Chinese).
|
|
56
|
Lee J, Suh C, Park YH, et al: Extranodal
natural killer T-cell lymphoma, nasal-type: a prognostic model from
a retrospective multicenter study. J Clin Oncol. 24:612–618.
2006.
|
